International Cancer Imaging Society

International Cancer Imaging Society Meeting and 17th Annual Teaching Course

Cancer Imaging and Intervention: A Multidisciplinary   Approach

Mon 02 Oct 2017 - Wed 04 Oct 2017

Langenbeck-Virchow Haus, Berlin, Germany

Meeting President: Prof. Dr. med Stefan Diederich, Düsseldorf

» Further Information  

» Register Here  

» Submit an Abstract  

In association with:

DRG

» View our Promotional Video

Interactive Workshops

Masterclass in Imaging of Thoracic Neoplasms

Wed 3 May 2017  London, UK 

  Highlighting the application of the new TNM  

   (8th edition) staging system  for lung cancer  

These one day teaching courses are limited to 40 participants, each with their own imaging workstation and content delivered through lectures and hands-on case based learning.

» Further Information  

» Register Here  

ICIS 2017 - Sponsored Delegate Opportunity

The International Cancer Imaging Society attracts delegates from over 30 countries to it's teaching course each year. As a registered charity, we would like to ensure we have delegates in attendance from some of the world's least developed and developing countries, where funding travel to Berlin and ICIS registration fees may not be possible.

The ICIS Secretariat invites any individual from any country categorised by the World Bank as 'low income' or 'lower middle income', to apply to be a sponsored delegate at ICIS 2017. The list can be found here

If you are interested, please submit the following:

- A written application 
- Your CV
- A supporting letter from your Head of Department

Applications will be reviewed on a case by case basis. Level of funding to be determined by the ICIS Executive Board.

Please send your written application, or any questions to admin@cancerimagingsociety.org.uk

Applications must be received by the 30th June. 

 

About ICIS

The International Cancer Imaging Society exists to meet the important challenges of advancing imaging in the multidisciplinary management of cancer.

We promote education in oncological imaging and stimulate research in the study of human tumour behaviour, bringing together radiologists with an interest in oncological imaging for the exchange of ideas, and to organise scientific meetings, multicentre research studies and postgraduate courses within the field.

 

» President's Message 

» Latest News 

Join our Society

Do you believe that Cancer Imaging is important?

If your answer is yes, join us to support and promote the education in oncological imaging and stimulate research in the study of human tumour behaviour.

As a member you will also receive:

  • Discounted registration fees for all our teaching courses
  • Exclusive access to the members' area
  • Exclusive access to posters and presentations from the annual teaching course
  • 20% off the APC for submitting manuscripts to Cancer Imaging

» Join now 

Come and see us at Leipzig!
21 April 2017

Come and see us at Leipzig!

ICIS will be exhibiting at the 98th Roentgen Conference in the Leipzig Congress Centre, Leipzig, Germany 24th to 27th May 2017 

http://www.roentgenkongress.de/de-DE/3099/international

Our Fellows Stefan Diederich (DE), Wolfgang Schima (AT), Gianni Morana (IT), Andrea Rockall (UK) and Jay Heiken (USA) will all be giving lectures on Wednedsay 24th May 2017 during the DRG meets ICIS sessions.

» Read more

Thoroughly impressed by the organisation, quality of presentations, content and the people and city of Glasgow! Meeting colleagues from around the world who have a passion for cancer imaging was a real treat.  Congratulations!

ADVDA | US

The conference facilities and location were excellent.  All credit to the organisers for another fantastic course!

AY | Cardiff, UK

Register your interest for all ICIS interactive courses

Please click on the link below to register your interest for future ICIS interactive courses.  We will notify you in advance of registration opening, allowing you first refusal on this popular range of courses.

To register your interest, fill in the details below and click on the "Register Interest" button.






Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

Diet tips for a healthy gallbladder

Published: Fri, 28 Apr 2017 13:00:00 GMT

What is a gallbladder diet and what foods support a gallbladder diet? Learn about which foods to avoid and the diet to follow after gallbladder surgery.

FDA expands approved use of Stivarga to treat liver cancer

Published: Fri, 28 Apr 2017 13:00:00 GMT

The U.S. Food and Drug Administration has expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been...

Italian-style coffee could halve the risk of prostate cancer

Published: Thu, 27 Apr 2017 16:00:00 GMT

Drinking at least three cups of Italian-style coffee every day may lower men's risk of prostate cancer by more than 50 percent, new research suggests.

Gallbladder cancer rates decreasing in men, not women; late-stage diagnosis on the rise

Published: Thu, 27 Apr 2017 07:00:00 GMT

Gallbladder cancer is a rare, but aggressive disease. According to the Centers for Disease Control and Prevention, about 3,700 people in the United States are diagnosed with gallbladder cancer each...

Worldwide statistics on breast cancer: Diagnosis and risk factors

Published: Wed, 26 Apr 2017 10:00:00 GMT

In this article, learn about statistics on breast cancer, if diet and obesity are risk factors, and racial differences within the U.S. for breast cancer.

Implanted scaffold with T cells rapidly shrinks tumors

Published: Wed, 26 Apr 2017 07:00:00 GMT

Cellular therapy hasn't had much success in fighting solid tumors, partly because it's been difficult to deliver anti-cancer T cells to the tumors.

Advanced liver cancer: Selective internal radiation therapy safer than sorafenib

Published: Tue, 25 Apr 2017 14:00:00 GMT

A phase III trial of selective internal radiation therapy for hepatocellular carcinoma has found the treatment is safer and just as effective as sorafenib.

Nanovaccine shows potential as immunotherapy for cancer

Published: Tue, 25 Apr 2017 14:00:00 GMT

Nanoparticles that carry antigens can promote immune response that slows tumor growth and extends survival in several mouse models of cancer, study shows.

Study identifies hundreds of genes that influence timing of puberty and alter risk of several cancers

Published: Tue, 25 Apr 2017 13:00:00 GMT

The largest genomic analysis of puberty timing in men and women conducted to date has identified 389 genetic signals associated with puberty timing, four times the number that were previously known.

A third of emergency cancer patients in England haven't seen their GP

Published: Tue, 25 Apr 2017 07:00:00 GMT

Around one third (34 per cent) of cancer patients diagnosed as an emergency in England had not consulted their doctor beforehand, according to a Cancer Research UK funded study published in the...

Beta blocker shows cancer-fighting properties

Published: Tue, 25 Apr 2017 07:00:00 GMT

A new study finds that carvedilol, a drug typically used to treat high blood pressure, can protect against the sun-induced cell damage that leads to skin cancer.

Compound in aged cheese may prevent liver cancer, boost longevity

Published: Mon, 24 Apr 2017 16:00:00 GMT

Spermidine - a compound found in aged cheese, mushrooms, and other foods - helped to prevent liver cancer and increase lifespan in mice, new study reveals.

Second cancers deadlier in young patients

Published: Mon, 24 Apr 2017 07:00:00 GMT

Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages...

Thousands of rare cancer-related gene mutations found

Published: Fri, 21 Apr 2017 07:00:00 GMT

Using a new statistical approach, researchers have uncovered thousands of genetic mutations that might be involved in cancer development.

Research team discovers how immunotherapy can fight some cancers

Published: Fri, 21 Apr 2017 07:00:00 GMT

What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment - immunotherapy.

Top research projects from the University of Illinois at Chicago

Published: Thu, 20 Apr 2017 15:00:00 GMT

Researchers from the University of Illinois at Chicago are constantly pushing boundaries. In this Spotlight feature, we will discuss some recent advances.

Drug based on malaria protein shows promise against treatment-resistant bladder cancer

Published: Thu, 20 Apr 2017 14:00:00 GMT

Mouse study finds that treating cisplatin-resistant bladder cancer with a recombinant protein from the malaria parasite has significant anti-tumor effect.

UCLA scientists combine a peptide with a nano cancer drug formulation to improve treatment effectiveness and prevent metastasis in pancreatic cancer

Published: Thu, 20 Apr 2017 07:00:00 GMT

Study shows the peptide enhances a vascular access pathway for nanocarriers in pancreatic cancer.

Immune system can spot tell-tale change in identity of cancer antigens - study

Published: Thu, 20 Apr 2017 07:00:00 GMT

A new study has identified novel mechanisms whereby T cells may be able to distinguish an emerging class of targets specifically increased on cancer cells.

What makes pancreatic cancer so aggressive?

Published: Thu, 20 Apr 2017 07:00:00 GMT

Pancreatic cancer is one of the most aggressive tumour types because it starts forming metastases early. The cancer itself, however, is usually only discovered late.